Understanding the role of TIPS in improving renal function amid cirrhosis

Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver function deteriorates.

United Therapeutics sues FDA over handling of Liquidia’s NDA – Pharmaceutical Technology

Share this article Tyvaso has entered blockbuster territory, seeing global sales of $1.2bn in 2023, up 41% from 2022 sales. Image credit: Shutterstock/viewimage. United Therapeutics

February 22, 2024

SomaLogic, co-founder of acquired company battle in court over unvested stock

Proteomics biotech SomaLogic and the co-founder of a company it bought last year are suing each other in separate court battles playing out in Colorado

July 13, 2023

BIOSECURE grandfather amendment softens US-China trade ban

An amendment to the US BIOSECURE bill will allow existing contracts with Chinese companies to be “grandfathered” in for eight years, reducing disruption to pharma

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.